The Cooper Companies, Inc.
A maker of contact lenses and fertility and women's-health products, The Cooper Companies runs two businesses: CooperVision, with brands like Biofinity, MyDay, and clariti 1 day, and CooperSurgical, maker of the Paragard hormone-free IUD and IVF devices. It began in 1958 when a Wall Street lawyer named Parker Montgomery bought a small healthcare firm, later renaming it Cooper Laboratories and then The Cooper Companies. Its MiSight 1 day lens is the only contact lens the FDA has approved to slow nearsightedness in children.
Granted 1.68M · Bought 5.5K · Sold 1.47M
Granted 514.0K · Bought 27.5K · Sold 324.7K
Granted 480.5K · Bought 5.0K · Sold 366.1K
Granted 37.6K · Bought 20.0K
Granted 37.0K · Bought 3.0K
Granted 430.3K · Bought 1.0K · Sold 365.1K
Granted 145.6K · Bought 7.0K · Sold 133.1K
Granted 22.9K
Granted 392.3K · Bought 30.0K · Sold 448.3K
Granted 12.8K · Bought 270
Granted 62.1K · Bought 1.5K · Sold 31.4K
Granted 120.1K · Bought 4.5K · Sold 110.9K
Granted 73.0K · Sold 40.9K
Granted 27.3K · Bought 1.4K · Sold 1.2K
Granted 107.5K · Bought 2.5K · Sold 89.2K
Granted 170.1K · Bought 3.0K · Sold 167.4K
Granted 235.8K · Bought 1.5K · Sold 207.3K
Granted 10.5K
Bought 2.0K
Granted 10.1K · Bought 1.0K
Granted 9.4K · Bought 1.8K
Granted 171.4K · Sold 171.5K
Granted 21.5K · Sold 18.9K
Granted 166.9K · Sold 166.6K
Granted 49.7K · Sold 49.7K
Granted 7.1K · Bought 4.0K
Granted 832
Granted 298.3K · Sold 267.3K
Granted 199.2K · Sold 179.2K
Granted 130.5K · Sold 116.4K
Granted 176.8K · Bought 348 · Sold 178.2K
Granted 89.6K · Bought 1.0K · Sold 77.3K
Granted 4.0K · Sold 902.6K
Bought 2.3K
Granted 8.3K · Sold 8.3K
Granted 4.0K · Sold 4.0K
Granted 3.5K
Granted 3.0K
Granted 14.8K · Sold 10.1K
Granted 4.3K
Granted 2.2K
Granted 14.9K · Sold 8.3K
Granted 16.5K · Sold 16.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Weiss Robert SDirector · 134 transactions | — | 550.5K | 1.68M | 5.5K | 1.47M |
| White Albert G IIIPresident & CEO, Director · 122 transactions | — | 254.5K | 514.0K | 27.5K | 324.7K |
| McBride Daniel GEVP & Chief Operating Officer · 135 transactions | — | 166.0K | 480.5K | 5.0K | 366.1K |
| Marx MosesDirector · 7 transactions | — | 107.5Kas of Dec 2009 | 37.6K | 20.0K | — |
| Sheffield Holly RPresident, CSI · 34 transactions | — | 47.1K | 37.0K | 3.0K | — |
| Kaufman Carol REVP, Sec. & Chief Gov. Officer · 105 transactions | — | 45.9Kas of Apr 2018 | 430.3K | 1.0K | 365.1K |
| Press DonaldDirector · 81 transactions | — | 44.0Kas of Jan 2014 | 145.6K | 7.0K | 133.1K |
| Jay ColleenDirector · 13 transactions | — | 39.9K | 22.9K | — | — |
| Bender A ThomasDirector · 235 transactions | — | 37.2Kas of Apr 2020 | 392.3K | 30.0K | 448.3K |
| Kozy William ADirector · 12 transactions | — | 31.1Kas of Apr 2025 | 12.8K | 270 | — |
| Andrews Brian GEVP, CFO & Treasurer · 61 transactions | — | 30.7K | 62.1K | 1.5K | 31.4K |
| Midlock Eugene JVP Tax · 19 transactions | — | 25.0Kas of Jan 2012 | 120.1K | 4.5K | 110.9K |
| Matz Gregory WSVP, CFO & CRO · 54 transactions | — | 23.8Kas of Jun 2016 | 73.0K | — | 40.9K |
| Warner Gerard H IIIPresident, CooperVision, Inc. · 44 transactions | — | 21.0K | 27.3K | 1.4K | 1.2K |
| Lindell Jody SDirector · 58 transactions | — | 19.8Kas of Jan 2023 | 107.5K | 2.5K | 89.2K |
| Zinberg Stanley MDDirector · 75 transactions | — | 16.3Kas of Mar 2019 | 170.1K | 3.0K | 167.4K |
| Weber John ArthurPresident, CooperVision, Inc. · 56 transactions | — | 16.2Kas of Jan 2014 | 235.8K | 1.5K | 207.3K |
| Madden Teresa SDirector · 6 transactions | — | 15.7K | 10.5K | — | — |
| Battin B NorrisVP, Investor Relations · 1 transaction | — | 15.3Kas of Oct 2006 | — | 2.0K | — |
| Rivas MariaDirector · 8 transactions | — | 14.5K | 10.1K | 1.0K | — |
| Lucchese Cynthia LDirector · 5 transactions | — | 12.8K | 9.4K | 1.8K | — |
| Kalkstein MichaelDirector · 66 transactions | — | 12.6Kas of Apr 2020 | 171.4K | — | 171.5K |
| Petersmeyer Gary SDirector · 55 transactions | — | 12.4Kas of Mar 2024 | 21.5K | — | 18.9K |
| Rosenberg StevenDirector · 53 transactions | — | 12.4Kas of Jan 2016 | 166.9K | — | 166.6K |
| Calcagno John JCFO - CooperVision · 10 transactions | — | 11.5Kas of Mar 2007 | 49.7K | — | 49.7K |
| Kurzius Lawrence ErikDirector · 5 transactions | — | 11.1K | 7.1K | 4.0K | — |
| Rosebrough Walter M JrDirector · 1 transaction | — | 10.8K | 832 | — | — |
| Remmell Paul LPres & CEO - CooperSurgical · 85 transactions | — | 10.6Kas of Jul 2017 | 298.3K | — | 267.3K |
| Pichotta Nicholas JPres, CEO Cooper Medical, Inc. · 60 transactions | — | 9.9Kas of Jan 2014 | 199.2K | — | 179.2K |
| Folden RodneyVP & Corporate Controller · 56 transactions | — | 8.3Kas of Jan 2014 | 130.5K | — | 116.4K |
| Rubenstein Allan EDirector · 113 transactions | — | 8.2Kas of Apr 2020 | 176.8K | 348 | 178.2K |
| Ricupati AgostinoSVP & CAO · 108 transactions | — | 8.0Kas of Apr 2025 | 89.6K | 1.0K | 77.3K |
| Fruth John DDirector · 588 transactions | — | 7.2Kas of Jan 2008 | 4.0K | — | 902.6K |
| Neil Steven MEVP & CFO · 3 transactions | — | 4.3Kas of Jan 2008 | — | 2.3K | — |
| Murphy DennisPresident Americas, CVI · 4 transactions | — | 4.2Kas of Sep 2009 | 8.3K | — | 8.3K |
| McLean Jeffrey AlanPres - U.S. Ops - CVI · 2 transactions | — | 4.0Kas of Jun 2007 | 4.0K | — | 4.0K |
| Khadder NicholasVP, General Counsel & Corp Sec · 5 transactions | — | 3.8Kas of Jan 2025 | 3.5K | — | — |
| Carbone BarbaraDirector · 1 transaction | — | 3.0K | 3.0K | — | — |
| Auerbach Robert DSpecial Advisor to the CEO · 54 transactions | — | 3.0Kas of Feb 2021 | 14.8K | — | 10.1K |
| Maloney TinaVP, Corporate Controller · 32 transactions | — | 2.7Kas of Jan 2017 | 4.3K | — | — |
| Drury Mark JVP, General Counsel & Sec. · 20 transactions | — | 2.2Kas of Jan 2022 | 2.2K | — | — |
| Golden RandalVP, General Counsel & Sec. · 61 transactions | — | 2.0Kas of Feb 2020 | 14.9K | — | 8.3K |
| Sedgwick AndrewPresident, EMEA · 2 transactions | — | 0as of Sep 2009 | 16.5K | — | 16.5K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -5.80M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.